공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 생물제제 시장 기회와 전략(-2030년) : COVID-19의 영향과 회복

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

리서치사 The Business Research Company
발행일 2020년 12월 상품 코드 980091
페이지 정보 영문 391 Pages
가격
US $ 6,000 ₩ 6,927,000 PDF (Single User License)
US $ 9,000 ₩ 10,390,000 PDF (Site License)
US $ 12,000 ₩ 13,854,000 PDF (Enterprise License)


세계의 생물제제 시장 기회와 전략(-2030년) : COVID-19의 영향과 회복 Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery
발행일 : 2020년 12월 페이지 정보 : 영문 391 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 생물제제(Biologics) 시장에 대해 조사했으며, 시장 규모와 예측, 동향과 전략, 성장 촉진요인 및 억제요인, COVID-19의 영향, 종류·투여 경로·구입 모드·의약품 분류·유통 채널·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 목차

제3장 그림목차

제4장 표목차

제5장 보고서 구조

제6장 서론

  • 지역별 세분화
  • 종류별 세분화
    • 단일클론항체(MAbS)
    • 치료용 단백질
    • 백신
  • 투여 경로별 세분화
  • 구입 모드별 세분화
  • 유통 채널별 세분화

제7장 생물제제 시장 특징

  • 시장 정의
  • 종류별 세분화
    • 치료용 단백질
    • 단일클론항체((MAbS)
    • 백신
  • 투여 경로별 세분화
    • 경구
    • 기타(IV 및 IP)
  • 의약품 분류별 세분화
    • 브랜드약
    • 제네릭 의약품
  • 구입 모드별 세분화
    • 처방약
    • OTC 의약품
  • 유통 채널별 세분화
    • 병원 약국
    • 소매 약국
    • 온라인 약국

제8장 생물제제 시장, 공급망 분석

  • 원재료 공급업체
  • 연구개발
    • 임상 연구
    • 수탁조사기관(CRO)
    • 승인
  • 생물제제 제조
    • 수탁제조기관(CMO)
  • 유통
    • 도매업체/유통업체
    • 소매업체
    • 이용자

제9장 제품 분석 - 제품 예

제10장 시장 고객 정보

  • 바이오시밀러 및 생물제제에 대한 환자 인식
  • 바이오시밀러 채용에 관한 인식
  • 생물학적 제제보다 바이오시밀러에 대한 환자 선호
  • 부작용 적은 인플루엔자 백신 선호
  • 부작용에 의한 예방 접종 백신에 대한 환자 주저

제11장 시장 동향과 전략

  • 생물제제 의약품 개발을 촉진하기 위해 개정된 FDA 규제
  • 생물제제의 보다 높은 이익률
  • 소분자로부터 생물제제로의 이동
  • 철저한 연구개발
  • 복잡한 질병 치료에서의 생물제제 수요

제12장 생물제제 시장에 대한 Covid-19의 영향

  • 연구개발 자금에 대한 영향
  • 공급망에 대한 영향
  • 회복

제13장 세계의 생물제제 시장 규모와 성장

  • 시장 규모
  • 시장 성장 : 매출 실적(2015-2019)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 성장 : 매출 예측(2019-2023, 2025F, 2030F)

제14장 생물제제 시장, 지역 분석

  • 시장 매출 실적과 예측(2015-2019, 2023, 2025, 2030)
  • 시장 실적과 예측(2015-2023)
  • 시장 성장과 점유율 비교(2019-2023)

제15장 세계 시장 세분화

  • 종류별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 단일클론항체
    • 치료용 단백질
    • 백신
    • 단일클론항체(MAbS) 종류별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 항암 MAbS
    • 면역학적 MAbS
    • 항감염성 단일클론항체(MAbS)
    • 심혈관 및 뇌혈관 MAbS
    • 신경약리학적 MABS
    • 기타 - 단일클론항체(MAb)
    • 치료용 단백질 종류별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 대사장애 치료 단백질
    • 암 치료 단백질
    • 심혈관 치료 단백질
    • 면역학적 치료 단백질
    • 기타 - 치료용 단백질
    • 백신 종류별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 항감염증 백신
    • 자가면역 백신
    • 기타 - 백신
  • 투여 경로별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 경구
    • 기타
  • 의약품 분류별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 브랜드약
    • 제네릭 의약품
  • 구입 모드별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 처방약
    • OTC 의약품
  • 유통 채널별 세분화 : 매출 실적 및 예측(2015-2019, 2023F, 2025F, 2030F)
    • 병원 약국
    • 소매 약국
    • 온라인 약국

제16장 거시경제 요인과 세계의 생물제제 시장 비교

  • 생물제제 시장 규모, GDP의 비율
  • 1인당 평균 생물제제 시장 지출

제17장 아시아태평양 생물제제 시장

제18장 서유럽의 생물제제 시장

제19장 동유럽의 생물제제 시장

제20장 북미의 생물제제 시장

제21장 남미의 생물제제 시장

제22장 중동의 생물제제 시장

제23장 아프리카의 생물제제 시장

제24장 경쟁 상황

  • 기업 개요
  • Pfizer Inc.
  • F. Hoffmann-La Roche AG
  • AbbVie Inc.
  • Merck & Co., Inc., Inc.
  • Johnson & Johnson

제25장 주요 합병과 인수

제26장 시장 배경 : 의약품 시장

  • 의약품 시장 특징
    • 시장 정의
    • 종류별 세분화
  • 종류별 매출(2015-2023)
  • 지역별 매출(2019)
  • 지역별 실적과 예측(2015-2023)

제27장 생물제제 시장 기회와 전략

  • 2023년 시장 : 가장 새로운 기회를 제공하는 국가
  • 2023년 시장 : 가장 새로운 기회를 제공하는 부문
  • 2023년 시장 : 성장 전략
    • 시장 동향 기반 전략
    • 경쟁 전략

제28장 생물제제 시장, 결론과 제안

  • 결론
  • 제안

제29장 부록

KSM 21.01.14

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the biologics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global biologics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, by distribution channel, by route of administration, by drug classification, and by mode of purchase.

Market Characteristics - The market characteristics section of the report defines and explains the biologics market. This chapter includes different products and services covered in the report and basic definitions.

Supply Chain - The supply chain section of the report defines and explains the key players in the biologics market supply chain.

Product Analysis - The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.

Customer Information- This chapters covers recent customers' trends/preferences in the global biologics market.

Trends And Strategies - This chapter describes the major trends shaping the global biologics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of COVID-19 - This section describes the impact of COVID-19 on the biologics market.

Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.

Market Segmentation - This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.

Regional Market Size And Growth - This section contains the region's market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).

Competitive Landscape - This section covers details on the competitive landscape of the global biologics market, estimated market shares and company profiles of the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for biologics companies in terms of product offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global biologics market is segmented into -

By Type: Therapeutic Proteins; Monoclonal Antibodies ((MAbS); Vaccines

Therapeutic Proteins are further segmented into- Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins

Monoclonal Antibodies (MAbS) are further segmented into- Anti-Cancer MABS; Immunological MABS; Anti-Infective Monoclonal Antibodies (MABS); Neuropharmacological Mabs; Cardiovascular And Cerebrovascular MABS; Others - Monoclonal Antibodies (MABS)

Vaccines are further segmented into- Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines

By Route Of Administration: Oral; Others (IV and IP)

By Drug Classification: Branded Drugs; Generic Drugs

By Mode Of Purchase: Prescription Drugs; Over-The-Counter (OTC) Drugs

By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Merck & Co., Inc.; Johnson & Johnson

Countries: China, Australia, Hong Kong, India, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Canada, Mexico, USA, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Czech Republic, Poland, Romania, Russia, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Biologics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Biologics Market Segmentation By Type
    • 6.2.1. Monoclonal Antibodies (MAbS) Segmentation By Type
    • 6.2.2. Therapeutic Proteins Segmentation By Type
    • 6.2.3. Vaccines Segmentation By Type
  • 6.3. Biologics Market Segmentation By Route Of Administration
  • 6.4. Biologics Market Segmentation By Mode Of Purchase
  • 6.5. Biologics Market Segmentation By Distribution Channel

7. Biologics Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By Type
    • 7.2.1. Therapeutic Proteins
    • 7.2.2. Monoclonal Antibodies ((MAbS)
    • 7.2.3. Vaccines
  • 7.3. Market Segmentation By Route Of Administration
    • 7.3.1. Oral
    • 7.3.2. Others (IV and IP)
  • 7.4. Market Segmentation By Drug Classification
    • 7.4.1. Branded Drugs
    • 7.4.2. Generic Drugs
  • 7.5. Market Segmentation By Mode Of Purchase
    • 7.5.1. Prescription Drugs
    • 7.5.2. Over-The-Counter (OTC) Drugs
  • 7.6. Market Segmentation By Distribution Channel
    • 7.6.1. Hospital Pharmacies
    • 7.6.2. Retail Pharmacies
    • 7.6.3. Online Pharmacies

8. Biologics Market, Supply Chain Analysis

  • 8.1. Raw Material Suppliers
  • 8.2. Research and Development
    • 8.2.1. Clinical Studies
    • 8.2.2. Contract Research Organization (CRO)
    • 8.2.3. Approval
  • 8.3. Biologics Manufacturing
    • 8.3.1. Contract Manufacturing Organization (CMO)
  • 8.4. Distribution
    • 8.4.1. Wholesalers/Distributors
    • 8.4.2. Retailers
    • 8.4.3. End Users

9. Biologics Market Product Analysis - Product Examples

10. Biologics Market Customer Information

  • 10.1. Awareness Of The Patients For Biosimilars And Biologics
  • 10.2. Perception On The Adoption Of Biosimilars
  • 10.3. Patients' Preference For Biosimilar Over Biologics
  • 10.4. Preference For Influenza Vaccines With Fewer Side Effects
  • 10.5. Hesitance Of Patients Towards Immunization Vaccines Due To Its Side Effects

11. Biologics Market Trends And Strategies

  • 11.1. Revised FDA Regulations To Facilitate Biologics Drug Development
  • 11.2. Higher Profit Margins For Biologics
  • 11.3. Shift From Small Molecules To Biologics
  • 11.4. Robust Research & Development
  • 11.5. Demand For Biologics In The Treatment Of Complex Diseases

12. Impact Of Covid-19 On Biologics Market

  • 12.1. Impact On R&D Funding
  • 12.2. Impact On Supply Chain
  • 12.3. Recovery

13. Global Biologics Market Size And Growth

  • 13.1. Market Size
  • 13.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 13.2.1. Drivers Of The Market 2015 - 2019
    • 13.2.2. Restraints On The Market 2015-19
  • 13.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 13.3.1. Drivers Of The Market 2019 - 2023
    • 13.3.2. Restraints On The Market 2019-2023

14. Biologics Market, Regional Analysis

  • 14.1. Global Biologics Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.2. Global Biologics Market, 2015 - 2023, Historic And Forecast, By Region
  • 14.3. Global Biologics Market, 2019-2023, Growth And Market Share Comparison, By Region

15. Global Biologics Market Segmentation

  • 15.1. Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.1. Monoclonal Antibodies
    • 15.1.2. Therapeutic Proteins
    • 15.1.3. Vaccines
    • 15.1.4. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.5. Anti-Cancer MAbS
    • 15.1.6. Immunological MAbS
    • 15.1.7. Anti-Infective Monoclonal Antibodies (MAbS)
    • 15.1.8. Cardiovascular And Cerebrovascular MAbS
    • 15.1.9. Neuropharmacological MABS
    • 15.1.10. Others - Monoclonal Antibodies (MAbs)
    • 15.1.11. Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.12. Metabolic Disorders Therapeutic Proteins
    • 15.1.13. Cancer Therapeutic Proteins
    • 15.1.14. Cardiovascular Therapeutic Proteins
    • 15.1.15. Immunological Therapeutic Proteins
    • 15.1.16. Others - Therapeutic Proteins
    • 15.1.17. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.1.18. Anti-Infective Vaccines
    • 15.1.19. Autoimmunity Vaccines
    • 15.1.20. Others-Vaccines
  • 15.2. Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.2.1. Oral
    • 15.2.2. Others
  • 15.3. Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.3.1. Branded Drugs
    • 15.3.2. Generic Drugs
  • 15.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.4.1. Prescription Drugs
    • 15.4.2. OTC Drugs
  • 15.5. Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies

16. Global Biologics Market Comparison with Macro Economic Factors

  • 16.1. Biologics Market Size, Percentage Of GDP, Global
  • 16.2. Per Capita Average Biologics Market Expenditure, Global

17. Asia-Pacific Biologics Market

  • 17.1. Asia-Pacific Biologics Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Impact Of COVID-19
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. Asia-Pacific Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.3. Asia-Pacific Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.4. Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.5. Asia-Pacific Biologics Market, 2019, By Country, Value ($ Million)
  • 17.6. Asia-Pacific Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 17.7. Asia-Pacific Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 17.8. Asia-Pacific Biologics Market Metrics
    • 17.8.1. Per Capita Biologics Expenditure, 2019, Asia-Pacific Major Countries
    • 17.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
    • 17.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
  • 17.9. Asia-Pacific Biologics Market: Country Analysis
  • 17.10. Australia Biologics Market
  • 17.11. Australia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.12. Australia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.13. Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.14. China Biologics Market
  • 17.15. China Biologics Market Overview
    • 17.15.1. Country Information
    • 17.15.2. Market Information
    • 17.15.3. Impact Of COVID-19
    • 17.15.4. Background Information
    • 17.15.5. Government Initiatives
    • 17.15.6. Regulations
    • 17.15.7. Regulatory Bodies
    • 17.15.8. Major Associations
    • 17.15.9. Taxes Levied
    • 17.15.10. Corporate Tax Structure
    • 17.15.11. Investments
    • 17.15.12. Major Companies
  • 17.16. China Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.17. China Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.18. China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.19. Hong Kong Biologics Market
  • 17.20. Hong Kong Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.21. Hong Kong Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.22. India Biologics Market
  • 17.23. India Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.24. India Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.25. India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.26. Indonesia Biologics Market
  • 17.27. Indonesia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.28. Indonesia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.29. Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.30. Japan Biologics Market
  • 17.31. Japan Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.32. Japan Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.33. Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.34. Malaysia Biologics Market
  • 17.35. Malaysia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.36. Malaysia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.37. New Zealand Biologics Market
  • 17.38. New Zealand Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.39. New Zealand Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.40. Philippines Biologics Market
  • 17.41. Philippines Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.42. Philippines Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.43. Singapore Biologics Market
  • 17.44. Singapore Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.45. Singapore Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.46. South Korea Biologics Market
  • 17.47. South Korea Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.48. South Korea Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.49. South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.50. Thailand Biologics Market
  • 17.51. Thailand Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.52. Thailand Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.53. Vietnam Biologics Market
  • 17.54. Vietnam Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.55. Vietnam Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

18. Western Europe Biologics Market

  • 18.1. Western Europe Biologics Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. COVID Impact
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Western Europe Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.3. Western Europe Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.4. Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.5. Western Europe Biologics Market, 2019, By Country, Value ($ Million)
  • 18.6. Western Europe Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 18.7. Western Europe Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 18.8. Western Europe Biologics Market Metrics
    • 18.8.1. Per Capita Biologics Expenditure, 2019, Western Europe Major Countries
    • 18.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
    • 18.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
  • 18.9. Western Europe Biologics Market: Country Analysis
  • 18.10. Austria Biologics Market
  • 18.11. Austria Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.12. Austria Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.13. Belgium Biologics Market
  • 18.14. Belgium Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.15. Belgium Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.16. Denmark Biologics Market
  • 18.17. Denmark Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.18. Denmark Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.19. Finland Biologics Market
  • 18.20. Finland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.21. Finland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.22. France Biologics Market
  • 18.23. France Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.24. France Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.25. France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.26. Germany Biologics Market
  • 18.27. Germany Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.28. Germany Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.29. Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.30. Ireland Biologics Market
  • 18.31. Ireland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.32. Ireland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.33. Italy Biologics Market
  • 18.34. Italy Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.35. Italy Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.36. Italy Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.37. Netherlands Biologics Market
  • 18.38. Netherlands Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.39. Netherlands Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.40. Norway Biologics Market
  • 18.41. Norway Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.42. Norway Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.43. Portugal Biologics Market
  • 18.44. Portugal Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.45. Portugal Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.46. Spain Biologics Market
  • 18.47. Spain Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.48. Spain Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.49. Spain Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.50. Sweden Biologics Market
  • 18.51. Sweden Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.52. Sweden Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.53. Switzerland Biologics Market
  • 18.54. Switzerland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.55. Switzerland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.56. UK Biologics Market
  • 18.57. UK Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.58. UK Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.59. UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Eastern Europe Biologics Market

  • 19.1. Eastern Europe Biologics Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Major Associations
    • 19.1.8. Taxes Levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Eastern Europe Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.3. Eastern Europe Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.4. Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.5. Eastern Europe Biologics Market, 2019, By Country, Value ($ Million)
  • 19.6. Eastern Europe Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 19.7. Eastern Europe Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 19.8. Eastern Europe Biologics Market Metrics
    • 19.8.1. Per Capita Biologics Expenditure, 2019, Eastern Europe Major Countries
    • 19.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
    • 19.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
  • 19.9. Eastern Europe Biologics Market: Country Analysis
  • 19.10. Czech Republic Biologics Market
  • 19.11. Czech Republic Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.12. Czech Republic Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.13. Poland Biologics Market
  • 19.14. Poland Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.15. Poland Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.16. Romania Biologics Market
  • 19.17. Romania Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.18. Romania Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.19. Russia Biologics Market
  • 19.20. Russia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.21. Russia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.22. Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. North America Biologics Market

  • 20.1. North America Biologics Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Impact Of COVID-19
    • 20.1.4. Background Information
    • 20.1.5. Government Initiatives
    • 20.1.6. Regulations
    • 20.1.7. Regulatory Bodies
    • 20.1.8. Major Associations
    • 20.1.9. Taxes Levied
    • 20.1.10. Corporate Tax Structure
    • 20.1.11. Investment
    • 20.1.12. Major Companies
  • 20.2. North America Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.3. North America Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.4. North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.5. North America Biologics Market, 2019, By Country, Value ($ Million)
  • 20.6. North America Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 20.7. North America Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 20.8. North America Biologics Market Metrics
    • 20.8.1. Per Capita Biologics Expenditure, 2019, North America Major Countries
    • 20.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
    • 20.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
  • 20.9. North America Biologics Market: Country Analysis
  • 20.10. Canada Biologics Market
  • 20.11. Canada Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.12. Canada Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.13. Mexico Biologics Market
  • 20.14. Mexico Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.15. Mexico Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.16. USA Biologics Market
  • 20.17. USA Biologics Market Overview
    • 20.17.1. Country Information
    • 20.17.2. Market Information
    • 20.17.3. COVID Impact
    • 20.17.4. Background Information
    • 20.17.5. Government Initiatives
    • 20.17.6. Regulations
    • 20.17.7. Regulatory Bodies
    • 20.17.8. Major Associations
    • 20.17.9. Taxes Levied
    • 20.17.10. Corporate Tax Structure
    • 20.17.11. Investment
    • 20.17.12. Major Companies
  • 20.18. USA Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 20.19. USA Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 20.20. USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

21. South America Biologics Market

  • 21.1. South America Biologics Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. COVID Impact
    • 21.1.4. Background Information
    • 21.1.5. Government Initiatives
    • 21.1.6. Regulations
    • 21.1.7. Regulatory Bodies
    • 21.1.8. Major Associations
    • 21.1.9. Taxes Levied
    • 21.1.10. Corporate Tax Structure
    • 21.1.11. Investments
    • 21.1.12. Major Companies
  • 21.2. South America Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.3. South America Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.4. South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.5. South America Biologics Market, 2019, By Country, Value ($ Million)
  • 21.6. South America Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 21.7. South America Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 21.8. South America Biologics Market Metrics
    • 21.8.1. Per Capita Biologics Expenditure, 2019, South America Major Countries
    • 21.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
    • 21.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
  • 21.9. South America Biologics Market: Country Analysis
  • 21.10. Argentina Biologics Market
  • 21.11. Argentina Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.12. Argentina Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.13. Brazil Biologics Market
  • 21.14. Brazil Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.15. Brazil Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.16. Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.17. Chile Biologics Market
  • 21.18. Chile Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.19. Chile Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.20. Colombia Biologics Market
  • 21.21. Colombia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.22. Colombia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.23. Peru Biologics Market
  • 21.24. Peru Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.25. Peru Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 21.26. Venezuela Biologics Market
  • 21.27. Venezuela Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 21.28. Venezuela Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

22. Middle East Biologics Market

  • 22.1. Middle East Biologics Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Impact Of COVID-19
    • 22.1.4. Background Information
    • 22.1.5. Government Initiatives
    • 22.1.6. Regulations
    • 22.1.7. Regulatory Bodies
    • 22.1.8. Major Associations
    • 22.1.9. Taxes Levied
    • 22.1.10. Corporate Tax Structure
    • 22.1.11. Investments
    • 22.1.12. Major Companies
  • 22.2. Middle East Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.3. Middle East Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.4. Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.5. Middle East Biologics Market, 2019, By Country, Value ($ Million)
  • 22.6. Middle East Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 22.7. Middle East Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 22.8. Middle East Biologics Market Metrics
    • 22.8.1. Per Capita Biologics Expenditure, 2019, Middle East Major Countries
    • 22.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
    • 22.8.3. Of the featured countries, Turkey had the lowest average revenue per enterprise in the biologics market with $ 1,681,534. As of 2019, there were 276 biologics enterprises in Turkey. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
  • 22.9. Middle East Biologics Market: Country Analysis
  • 22.10. Israel Biologics Market
  • 22.11. Israel Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.12. Israel Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.13. Saudi Arabia Biologics Market
  • 22.14. Saudi Arabia Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.15. Saudi Arabia Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.16. Turkey Biologics Market
  • 22.17. Turkey Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.18. Turkey Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 22.19. UAE Biologics Market
  • 22.20. UAE Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 22.21. UAE Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

23. Africa Biologics Market

  • 23.1. Africa Biologics Market Overview
    • 23.1.1. Region Information
    • 23.1.2. Market Information
    • 23.1.3. Impact Of COVID-19
    • 23.1.4. Background Information
    • 23.1.5. Government Initiatives
    • 23.1.6. Regulations
    • 23.1.7. Regulatory Bodies
    • 23.1.8. Major Associations
    • 23.1.9. Taxes Levied
    • 23.1.10. Corporate Tax Structure
    • 23.1.11. Investments
    • 23.1.12. Major Companies
  • 23.2. Africa Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.3. Africa Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.4. Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.5. Africa Biologics Market, 2019, By Country, Value ($ Million)
  • 23.6. Africa Biologics Market, 2015 - 2023, Historic And Forecast, By Country
  • 23.7. Africa Biologics Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 23.8. Africa Biologics Market Metrics
    • 23.8.1. Per Capita Biologics Expenditure, 2019, Africa Major Countries
    • 23.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
    • 23.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
  • 23.9. Africa Biologics Market: Country Analysis
  • 23.10. Egypt Biologics Market
  • 23.11. Egypt Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.12. Egypt Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.13. Nigeria Biologics Market
  • 23.14. Nigeria Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.15. Nigeria Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 23.16. South Africa Biologics Market
  • 23.17. South Africa Biologics Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 23.18. South Africa Biologics Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)

24. Global Biologics Market Competitive Landscape

  • 24.1. Company Profiles
  • 24.2. Pfizer Inc.
    • 24.2.1. Company Overview
    • 24.2.2. Products And Services
    • 24.2.3. Business Strategy
    • 24.2.4. Financial Overview
  • 24.3. F. Hoffmann-La Roche AG
    • 24.3.1. Company Overview
    • 24.3.2. Products And Services
    • 24.3.3. Business Strategy
    • 24.3.4. Financial Overview
  • 24.4. AbbVie Inc.
    • 24.4.1. Company Overview
    • 24.4.2. Products And Services
    • 24.4.3. Business Strategy
    • 24.4.4. Financial Overview
  • 24.5. Merck & Co., Inc., Inc.
    • 24.5.1. Company Overview
    • 24.5.2. Products And Services
    • 24.5.3. Business Strategy
    • 24.5.4. Financial Overview
  • 24.6. Johnson & Johnson
    • 24.6.1. Company Overview
    • 24.6.2. Products And Services
    • 24.6.3. Business Strategy
    • 24.6.4. Financial Overview

25. Key Mergers And Acquisitions In The Biologics Market

  • 25.1. Abbvie Acquired Allergan
  • 25.2. WuXi Biologics Acquired Drug Product Manufacturing Plant From Bayer
  • 25.3. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.
  • 25.4. True North Acquired Stake In Biocon Biologics
  • 25.5. Catalent, Inc. Acquired Bristol Myers Squibb's Oral Dose Manufacturing Facility
  • 25.6. Bristol Myers Acquired Celgene
  • 25.7. Evotec Acquired Just Biotherapeutics
  • 25.8. AstraZeneca Strikes Stock Deal With Daiichi Sankyo
  • 25.9. Boehringer Acquires Rights To ICD Therapeutics And Its Biologics-Delivery Platform
  • 25.10. Catalent, Inc. Acquired Cook Pharmica LLC
  • 25.11. ADMA Biologics Acquired Biotest's Therapy Business
  • 25.12. Eagle Pharmaceuticals Acquired Arsia Therapeutics
  • 25.13. Takeda Acquired Baxalta's Manufacturing Facility

26. Market Background: Pharmaceuticals Market

  • 26.1. Pharmaceuticals Market Characteristics
    • 26.1.1. Market Definition
    • 26.1.2. Segmentation By Type
  • 26.2. Global Pharmaceuticals Market, Segmentation By Type, 2015 - 2023, Value ($ Billion)
  • 26.3. Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
  • 26.4. Global Pharmaceuticals Market, 2015 - 2023, Historic And Forecast, By Region

27. Biologics Market Opportunities And Strategies

  • 27.1. Global Biologics Market In 2023 - Countries Offering Most New Opportunities
  • 27.2. Global Biologics Market In 2023 - Segments Offering Most New Opportunities
  • 27.3. Global Biologics Market In 2023 - Growth Strategies
    • 27.3.1. Market Trend Based Strategies
    • 27.3.2. Competitor Strategies

28. Biologics Market, Conclusions And Recommendations

  • 28.1. Conclusions
  • 28.2. Recommendations
    • 28.2.1. Product
    • 28.2.2. Place
    • 28.2.3. Price
    • 28.2.4. Promotion
    • 28.2.5. People

29. Appendix

  • 29.1. Market Data Sources
  • 29.2. Research Methodology
  • 29.3. Currencies
  • 29.4. Research Inquiries
  • 29.5. The Business Research Company
  • 29.6. Copyright and Disclaimer
Back to Top
전화 문의
F A Q